NO329330B1 - Fremgangsmate for fremstilling av benzoksazinderviater - Google Patents

Fremgangsmate for fremstilling av benzoksazinderviater Download PDF

Info

Publication number
NO329330B1
NO329330B1 NO20021124A NO20021124A NO329330B1 NO 329330 B1 NO329330 B1 NO 329330B1 NO 20021124 A NO20021124 A NO 20021124A NO 20021124 A NO20021124 A NO 20021124A NO 329330 B1 NO329330 B1 NO 329330B1
Authority
NO
Norway
Prior art keywords
compound
compound represented
following formula
group
formula
Prior art date
Application number
NO20021124A
Other languages
English (en)
Norwegian (no)
Other versions
NO20021124D0 (no
NO20021124L (no
Inventor
Kouji Sato
Yoshihiro Takayanagi
Katsuhiko Okano
Keiji Nakayama
Akihiro Imura
Mikihiro Itoh
Tsutomu Yagi
Yukinari Kobayashi
Tomoyuki Nagai
Original Assignee
Daiichi Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Sankyo Co Ltd filed Critical Daiichi Sankyo Co Ltd
Publication of NO20021124D0 publication Critical patent/NO20021124D0/no
Publication of NO20021124L publication Critical patent/NO20021124L/no
Publication of NO329330B1 publication Critical patent/NO329330B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/06Peri-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B57/00Separation of optically-active compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/04Formation of amino groups in compounds containing carboxyl groups
    • C07C227/06Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid
    • C07C227/08Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid by reaction of ammonia or amines with acids containing functional groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/30Preparation of optical isomers
    • C07C227/34Preparation of optical isomers by separation of optical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/36Racemisation of optical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/18Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to carbon atoms of six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/30Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and unsaturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/341,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/361,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds
    • C12P13/001Amines; Imines
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds
    • C12P13/02Amides, e.g. chloramphenicol or polyamides; Imides or polyimides; Urethanes, i.e. compounds comprising N-C=O structural element or polyurethanes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds
    • C12P13/04Alpha- or beta- amino acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/003Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
    • C12P41/005Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of carboxylic acid groups in the enantiomers or the inverse reaction
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20021124A 1999-09-08 2002-03-06 Fremgangsmate for fremstilling av benzoksazinderviater NO329330B1 (no)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP25395899 1999-09-08
JP27801999 1999-09-30
JP2000239256 2000-08-08
JP2000239262 2000-08-08
PCT/JP2000/006094 WO2001018005A1 (fr) 1999-09-08 2000-09-07 Procede de preparation de derives de benzoxazine et de leurs intermediaires

Publications (3)

Publication Number Publication Date
NO20021124D0 NO20021124D0 (no) 2002-03-06
NO20021124L NO20021124L (no) 2002-05-08
NO329330B1 true NO329330B1 (no) 2010-09-27

Family

ID=27478308

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20021124A NO329330B1 (no) 1999-09-08 2002-03-06 Fremgangsmate for fremstilling av benzoksazinderviater
NO20100667A NO330090B1 (no) 1999-09-08 2010-05-07 Fremgangsmate for fremstilling av mellomprodukter av benzoksazinderivater

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20100667A NO330090B1 (no) 1999-09-08 2010-05-07 Fremgangsmate for fremstilling av mellomprodukter av benzoksazinderivater

Country Status (12)

Country Link
US (3) US6872823B1 (es)
EP (4) EP2218722B9 (es)
JP (5) JP4302350B2 (es)
KR (3) KR100947758B1 (es)
CN (2) CN100537519C (es)
AU (1) AU6873700A (es)
CA (3) CA2380359C (es)
ES (4) ES2409383T3 (es)
HK (1) HK1043131B (es)
NO (2) NO329330B1 (es)
TW (1) TWI254048B (es)
WO (1) WO2001018005A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6873700A (en) * 1999-09-08 2001-04-10 Daiichi Pharmaceutical Co., Ltd. Process for the preparation of benzoxazine derivatives and intermediates therefor
IL161164A0 (en) * 2001-10-03 2004-08-31 Teva Pharma Preparation of levofloxacin and forms thereof
US7425628B2 (en) * 2001-10-03 2008-09-16 Teva Pharmaceutical Industries Ltd. Methods for the purification of levofloxacin
US20090156577A1 (en) * 2004-09-09 2009-06-18 Benjamin Davis 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
CN100580009C (zh) * 2005-12-31 2010-01-13 四川东材科技集团股份有限公司 一种含硼苯并恶嗪树脂的制备方法
US7902227B2 (en) 2007-07-27 2011-03-08 Janssen Pharmaceutica Nv. C-7 isoxazolinyl quinolone / naphthyridine derivatives useful as antibacterial agents
CN101659669B (zh) * 2009-09-04 2011-07-20 诚达药业股份有限公司 左旋氧氟沙星的制备方法
CN101768167B (zh) * 2010-01-15 2012-07-04 浙江东亚药业有限公司 左氧氟沙星的缩哌合成方法
CN101836993B (zh) 2010-05-20 2011-06-22 山东大学 2,3-二氢-3-羟甲基-6-氨基-[1,4]-苯并噁嗪在制备诱导胚胎干细胞向血管内皮细胞分化药物中的应用
WO2012017343A2 (en) 2010-08-05 2012-02-09 Koninklijke Philips Electronics N.V. Cardiomyocyte containing device, manufacturing method and measuring method
CN103360409B (zh) * 2012-04-06 2016-02-10 天方药业有限公司 氧氟羧酸制备方法
WO2014179100A1 (en) * 2013-04-30 2014-11-06 3M Innovative Properties Company Process for preparing poly(benzoxazines)
WO2016209063A2 (ko) * 2015-06-25 2016-12-29 고려대학교 산학협력단 평균 밀도 조절이 가능한 구조체 및 이를 이용한 물질 전환 및 선택적 결합 공정
US20180324299A1 (en) * 2017-05-08 2018-11-08 T-Mobile Usa, Inc. Network-controlled robocall and scam call handling
CN112877217B (zh) * 2020-12-10 2022-04-15 贵州大学 一种黄褐奈尼兹皮真菌菌株及其降解鸡毛中的用途

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56417B2 (es) * 1973-07-05 1981-01-08
JPS5829789A (ja) 1981-08-17 1983-02-22 Dai Ichi Seiyaku Co Ltd ピリドベンズオキサジン誘導体
JPS5872588A (ja) * 1981-10-27 1983-04-30 Dai Ichi Seiyaku Co Ltd ピリド〔1,2,3−de〕−1,4−ベンゾオキサジン誘導体の製造法
DK170473B1 (da) 1985-06-20 1995-09-11 Daiichi Seiyaku Co S(-)-pyridobenzoxazinforbindelser
ZA864518B (en) 1985-06-20 1987-03-25 Daiichi Seiyaku Co Optically active pyridobenzoxazine derivatives and intermediates thereof
JPH0720946B2 (ja) 1985-10-11 1995-03-08 第一製薬株式会社 光学活性3−メチルベンゾオキサジン誘導体およびその製法
JP2573269B2 (ja) 1986-12-25 1997-01-22 第一製薬株式会社 光学活性ベンゾオキサジン
JP2612327B2 (ja) 1987-12-25 1997-05-21 第一製薬株式会社 プロポキシベンゼン誘導体およびその製法
FI95567C (fi) 1987-12-25 1996-02-26 Daiichi Seiyaku Co Propoksibentseenijohdannaisia ja menetelmä niiden valmistamiseksi
JP2769174B2 (ja) 1987-12-28 1998-06-25 第一製薬株式会社 縮合オキサジンの製法
ES2014560A6 (es) * 1988-12-30 1990-07-16 Marga Investigacion Proceso para la preparacion de un nuevo reactivo organo-sililpolifosforico y su aplicacion al proceso de sontesis de 3-carboxi-quinolonas o azaquinolonas y sus sales.
JP2771871B2 (ja) 1989-12-13 1998-07-02 第一製薬株式会社 光学活性プロポキシベンゼン誘導体の製法
KR920004385A (ko) * 1990-08-09 1992-03-27 와꾸나가 기스께 신규 삼환화합물 또는 그의 염, 이의 제조방법 및 이를 함유하는 항균제
DE69206306T2 (de) * 1991-04-08 1996-06-13 Sumitomo Chemical Co Optisch aktive Sekundär-Aminverbindung, Verfahren zur Herstellung einer optisch aktiven Sekundär-Aminverbindung und Verfahren zur Herstellung optisch aktiver Carbonsäure durch die Verwendung dieser Verbindung.
US5521310A (en) * 1992-10-07 1996-05-28 Derivados Del Etilo, S.A. Process to obtain benzoxazines to be used for the synthesis of ofloxazine, levofloxazine and derivatives
CN1066136C (zh) * 1994-07-21 2001-05-23 中国医药研究开发中心 吡啶并苯并噁嗪衍生物的中间体及其制备方法
US5644056A (en) * 1995-06-07 1997-07-01 Hoechst Celanese Corporation Method of preparing 7,8-difluoro-2,3-dihydro-3-methyl-4H-1, 4-benzoxazine
AU5585198A (en) * 1996-11-22 1998-06-10 Athena Pharmaceuticals, Inc. N-(aryl/heteroaryl) amino acid esters, pharmaceutical compositions, and ethods for inhibiting beta-amyloid peptide release and/or its synthesis
AU6873700A (en) * 1999-09-08 2001-04-10 Daiichi Pharmaceutical Co., Ltd. Process for the preparation of benzoxazine derivatives and intermediates therefor

Also Published As

Publication number Publication date
HK1043131B (zh) 2014-08-29
ES2409383T3 (es) 2013-06-26
EP2360160B1 (en) 2013-07-24
KR100947758B1 (ko) 2010-03-18
JP2009235077A (ja) 2009-10-15
US20060014947A1 (en) 2006-01-19
EP1211254A4 (en) 2006-05-03
KR100954299B1 (ko) 2010-04-23
JP4358296B2 (ja) 2009-11-04
KR20090077024A (ko) 2009-07-13
JP5149238B2 (ja) 2013-02-20
NO330090B1 (no) 2011-02-14
JP4358295B2 (ja) 2009-11-04
CN1195759C (zh) 2005-04-06
JP2009221209A (ja) 2009-10-01
US7189847B2 (en) 2007-03-13
CA2380359C (en) 2011-11-29
EP1211254A1 (en) 2002-06-05
ES2458545T3 (es) 2014-05-06
ES2472240T3 (es) 2014-06-30
EP2284174B1 (en) 2014-03-05
EP2218722B9 (en) 2013-06-19
CN1379779A (zh) 2002-11-13
US20050027119A1 (en) 2005-02-03
KR100914396B1 (ko) 2009-08-31
EP2284174A1 (en) 2011-02-16
JP2009167202A (ja) 2009-07-30
EP1211254B1 (en) 2014-05-07
KR20020035867A (ko) 2002-05-15
US7087778B2 (en) 2006-08-08
KR20090123026A (ko) 2009-12-01
TWI254048B (en) 2006-05-01
CN1532181A (zh) 2004-09-29
NO20021124D0 (no) 2002-03-06
CN100537519C (zh) 2009-09-09
EP2218722A2 (en) 2010-08-18
JP5106478B2 (ja) 2012-12-26
CA2660917A1 (en) 2001-03-15
NO20021124L (no) 2002-05-08
NO20100667L (no) 2002-05-08
EP2360160A1 (en) 2011-08-24
JP4302350B2 (ja) 2009-07-22
HK1043131A1 (en) 2002-09-06
CA2380359A1 (en) 2001-03-15
CA2660917C (en) 2012-01-03
WO2001018005A1 (fr) 2001-03-15
EP2218722B1 (en) 2013-03-13
EP2218722A3 (en) 2011-05-11
US6872823B1 (en) 2005-03-29
ES2424813T3 (es) 2013-10-08
WO2001018005A8 (fr) 2001-05-25
CA2685440C (en) 2011-11-15
CA2685440A1 (en) 2001-03-15
JP2009173665A (ja) 2009-08-06
AU6873700A (en) 2001-04-10

Similar Documents

Publication Publication Date Title
NO330090B1 (no) Fremgangsmate for fremstilling av mellomprodukter av benzoksazinderivater
AU2016366795B2 (en) New process and intermediates
EP1008590B1 (en) Process for preparing optically active oxazolidinone derivatives
RU2258069C2 (ru) Способ получения производного бензоксазина, способы получения его промежуточного соединения и промежуточные соединения
JP5329973B2 (ja) リパーゼ触媒を用いるエナンチオ選択的アシル化とその後の硫酸による沈殿によって、ラセミ体の4−(1−アミノエチル)安息香酸メチルエステルから(r)−および(s)−4−(1−アンモニウムエチル)安息香酸メチルエステル硫酸塩を調製する方法
JP2001163841A (ja) 光学活性な2−(2,3,4―トリハロゲノアニリノ)−プロピオン酸誘導体の製法
JP4257975B2 (ja) 光学活性アミノインダノール類及びアミノテトラリノール類の製造法

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees